Innovative Biotech Company Adopts Medidata Rave EDC, Benefiting From a Unified Platform for All Phases of the Study
PhaseBio is a clinical-stage biopharmaceutical company committed to developing improved biotherapeutics for the treatment of orphan diseases, with an initial focus on cardiopulmonary indications. Like many smaller, innovative life science companies, PhaseBio chose to partner with Medidata due to its unified eClinical platform, which drives better science and business through all phases of a study.
“We have a very good understanding of our entire program beginning with
Phase I all the way through Phase III, and know ahead of time that we
plan to start as a single site in Phase I, and rapidly expand as a
global program,” said
Additional comments can be found in this video.
Founded in 1999, Medidata sets the industry standard as the market leader in clinical trial technology. Built on a unified, SaaS platform, Medidata has built a community of life science leaders who are committed to leveraging their shared insights to solve some of the biggest patient, regulatory, and quality challenges in clinical development. Medidata's continued innovation and ability to replace legacy systems is driven by:
A unified platform - Pharmaceutical companies, device firms, and contract research organizations (CROs) of all sizes, specializing across all therapeutic areas, are using the Medidata Clinical Cloud. The global customer base includes 18 of the world's top 25 global pharmaceutical companies and 18 of the top 25 medical device companies.
Pioneering analytics and data - The Medidata Clinical Cloud
powers more than 14,000 studies involving more than 4 million trial
subjects, comprising more than 500,000 sponsor/site relationships.
Unrivaled expertise - Medidata’s professional services group
ranked top in the industry in a recent
“This is a remarkable accomplishment for both Medidata and the
Medidata's unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world. The Medidata Clinical Cloud® connects patients, physicians and life sciences professionals. Companies on the Medidata platform are individually and collaboratively reinventing the way research is done to create smarter, more precise treatments. For more information: www.mdsol.com